CXChen Xin

Chen Xin

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chen Xin has a total of 16 co-authors. Here are the top co-authors by number of shared publications:

  • Chenghui Mai

    Department of Neurosurgery, Southwest Hospital, Army Medical University, Chongqing, China

    1 shared publication
  • Fei Chen

    Department of Neurosurgery, Southwest Hospital, Army Medical University, Chongqing, China

    1 shared publication
  • Feng Chengjian

    Department of Medical Engineering, 958th Hospital of the People’s Liberation Army, Chongqing, China

    1 shared publication
  • Guangjian He

    Department of Neurosurgery, Southwest Hospital, Army Medical University, Chongqing, China

    1 shared publication
  • Hongyan Zhang

    Yunnan Institute of Medical Device Testing, Kunming, China

    1 shared publication
  • Jiangkai Lin

    Department of Neurosurgery, Institute of Neurosurgery, Key Laboratory of Neurotrauma Prevention and Treatment, Southwest Hospital, Third Military Medical University, Chongqing, China

    1 shared publication

Latest Publications

  • Open Access

    Resection and 3D-printed prosthetic reconstruction of a giant aneurysmal bone cyst in the atlas: illustrative case

    by Yuanwen Zheng, Xing Fang, Guangjian He, Xingsen Xue, Xin Chen, Chenghui Mai, Fei Chen, Weihua Chu

    BACKGROUND: Aneurysmal bone cysts (ABCs) are aggressive, destructive bone tumors. Treatment of ABCs occurring in the upper cervical spine remains challenging due to their proximity to critical nerves and blood vessels. OBSERVATIONS: The authors report the case of a patient with a giant ABC in the atlas. Imaging data showed that there were changes in the left bone of the atlas, spinal canal stenosis and instability at the craniovertebral junction, and the vertebral artery passed through the lesion. The combined far-lateral, transoral, and posterior midline approach was adopted to completely resect the lesion. Meanwhile, a personalized atlas prosthesis was fabricated by means of 3D printing to reconstruct the craniovertebral stability. After the operation, the patient’s symptoms disappeared and there was no neurological dysfunction. During the 3-year follow-up, the lesion did not recur and the prosthesis and internal fixation devices were in a good position. LESSONS: In this case of a giant ABC of atlas, the authors successfully achieved complete resection of atlas lateral mass lesions through a combined posterior-anterior-posterior approach and used a 3D-printed prosthesis to reconstruct craniocervical stability, providing a surgical paradigm for similar cases. https://thejns.org/doi/10.3171/CASE25164

  • Curcumin Improves Human Umbilical Cord-Derived Mesenchymal Stem Cell Survival via ERK1/2 Signaling and Promotes Motor Outcomes After Spinal Cord Injury

    by Wu Wanjiang, Chen Xin, Chen Yaxing, Wang Jie, Zhang Hongyan, Ni Fei, Ling Chengmin, Feng Chengjian, Yuan Jichao, Lin Jiangkai

    Human umbilical cord-derived mesenchymal stem cell (hUC-MSC) transplantation is thought to be a promising strategy for treating spinal cord injury (SCI). However, the low survival rate of transplanted hUC-MSCs limits their clinical application in cell replacement therapy. Curcumin can suppress inflammation after SCI; however, it remains unknown whether curcumin can modulate the survival of transplanted hUC-MSCs. In this study, to investigate whether curcumin could strengthen the therapeutic effects of hUC-MSC transplantation on SCI, we induced hUC-MSC apoptosis with TNF-α, transplanted hUC-MSC into SCI rats, and assessed the antiapoptotic effect and mechanism of curcumin. LDH release analysis and flow cytometry demonstrated that TNF-α led to hUC-MSC apoptosis and that curcumin increased the hUC-MSC survival rate in a dose-dependent manner. In addition, we showed that the phosphorylation levels of ERK1/2, JNK, and P38 were upregulated in apoptotic hUC-MSCs, while curcumin increased the phosphorylation of ERK1/2 but did not activate JNK or P38, and these effects were reversed by the p42/44 antagonist U0126. Furthermore, we found that the motor function scores and number of surviving HNA-positive cells were significantly increased after curcumin and hUC-MSC transplantation therapy 8 weeks post-SCI, while U0126 markedly attenuated these effects. These data confirmed that curcumin suppressed hUC-MSC apoptosis through the ERK1/2 signaling pathway and that combined curcumin and hUC-MSC treatment improved motor function in rats after SCI. The current research provides a strong basis for hUC-MSC replacement therapy in conjunction with curcumin in the treatment and management of SCI in humans.